Pasireotide

• Post Date:

  Aug 01,2017

• Expiry Date:

  Aug 01,2018

• Detailed Description:

  Cas No. :Pasireotide Payment Method: T/T
  Full Name：Pasireotide/p>
  Cas No：396091-73-9
  Molecular Formular: C58H66N10O9
  
  Molecular Weight: 1047.21
  
  Sequence：Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]
  
  
  Purity：≥98.0%
  
  Application field: Pasireotide (SOM230, trade name Signifor) is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

• CAS Registry Number:

  Pasireotide

• Molecular Structure:

  

• Company:

  Zhejiang Peptites Biotech Co., Ltd     [ China ]        

• Contact:

  Zoe

• Tel:

  +8657186698660

• Fax:

• Email:

  sales1@peptide-manufacturer.com